- Home
- PHAR vs IRMD Comparison
PHAR vs IRMD Comparison
Compare PHAR & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- IRMD
- Stock Information
- Founded
- PHAR 1988
- IRMD 1992
- Country
- PHAR Netherlands
- IRMD United States
- Employees
- PHAR N/A
- IRMD N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- IRMD Medical/Dental Instruments
- Sector
- PHAR Health Care
- IRMD Health Care
- Exchange
- PHAR Nasdaq
- IRMD Nasdaq
- Market Cap
- PHAR 618.3M
- IRMD 766.5M
- IPO Year
- PHAR N/A
- IRMD 2014
- Fundamental
- Price
- PHAR $8.20
- IRMD $60.86
- Analyst Decision
- PHAR Strong Buy
- IRMD Strong Buy
- Analyst Count
- PHAR 3
- IRMD 1
- Target Price
- PHAR $27.00
- IRMD $60.00
- AVG Volume (30 Days)
- PHAR 5.6K
- IRMD 36.9K
- Earning Date
- PHAR 03-13-2025
- IRMD 02-13-2025
- Dividend Yield
- PHAR N/A
- IRMD 0.98%
- EPS Growth
- PHAR N/A
- IRMD 13.16
- EPS
- PHAR N/A
- IRMD 1.46
- Revenue
- PHAR $285,745,000.00
- IRMD $71,305,130.00
- Revenue This Year
- PHAR $20.08
- IRMD $13.60
- Revenue Next Year
- PHAR $9.22
- IRMD $10.46
- P/E Ratio
- PHAR N/A
- IRMD $41.82
- Revenue Growth
- PHAR 30.64
- IRMD 13.23
- 52 Week Low
- PHAR $6.65
- IRMD $40.18
- 52 Week High
- PHAR $13.20
- IRMD $61.25
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- IRMD 57.38
- Support Level
- PHAR $8.49
- IRMD $59.63
- Resistance Level
- PHAR $9.35
- IRMD $61.09
- Average True Range (ATR)
- PHAR 0.55
- IRMD 1.53
- MACD
- PHAR -0.17
- IRMD -0.12
- Stochastic Oscillator
- PHAR 12.14
- IRMD 63.33
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.